Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...

A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing ...

Less than a month after researchers unveiled that a “ticking DNA clock” is behind Huntington’s disease (HD), scientists have ...

For several decades, people with HD will not exhibit any symptoms. However ... from abnormal numbers of DNA repeats, including fragile X syndrome and myotonic dystrophy. Encouraged by these ...

Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name of 'emestedastat' to Actinogen for its Xanamem ® /UE2343 once-a-day small ...

People with genetic disorders such as fragile X syndrome, Rett syndrome ... many girls and women have the condition. The symptoms may present differently, and they may learn to camouflage the ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.